‘Macro overshadowing micro’: Capitalmind AMC expects selling despite decent Q2 results

Anoop Vijaykumar of Capitalmind AMC expects pharma to remain resilient but sees a slower recovery for largecap IT, while staying cautious on consumption stocks amid rate hike concerns.

Leave a Reply

Your email address will not be published. Required fields are marked *